LADENBURG THALMANN FINANCIAL SERVICES INC. - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 53 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$5,0000.0%2,0000.0%0.00%
Q1 2018$5,000
-37.5%
2,0000.0%0.00%
Q4 2017$8,000
+60.0%
2,0000.0%0.00%
Q3 2017$5,000
-16.7%
2,0000.0%0.00%
Q2 2017$6,000
+50.0%
2,0000.0%0.00%
Q1 2017$4,000
+100.0%
2,0000.0%0.00%
Q4 2016$2,0000.0%2,0000.0%0.00%
Q3 2016$2,000
+100.0%
2,0000.0%0.00%
Q2 2016$1,000
-50.0%
2,0000.0%0.00%
Q1 2016$2,000
-60.0%
2,0000.0%0.00%
Q4 2015$5,000
-16.7%
2,0000.0%0.00%
Q3 2015$6,000
-25.0%
2,0000.0%0.00%
Q2 2015$8,000
-38.5%
2,000
-33.3%
0.00%
Q1 2015$13,000
-7.1%
3,000
-45.5%
0.00%
Q2 2014$14,000
+16.7%
5,5000.0%0.00%
Q1 2014$12,000
-29.4%
5,5000.0%0.00%
-100.0%
Q3 2013$17,0005,5000.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$1,902,0005.68%
GABLES CAPITAL MANAGEMENT INC. 433,814$5,566,0004.46%
Quantedge Capital Pte Ltd 503,700$6,462,0001.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,896,000$62,816,0001.25%
Lanham O'Dell & Company, Inc. 20,145$258,0000.92%
Capital Impact Advisors, LLC 59,301$907,0000.90%
SummerHaven Investment Management, LLC 98,840$1,268,0000.88%
Yorktown Management & Research Co Inc 50,000$642,0000.83%
GLOBEFLEX CAPITAL L P 304,293$3,904,0000.67%
AFFINITY INVESTMENT ADVISORS, LLC 90,864$1,166,0000.60%
View complete list of CATALYST PHARMACEUTICALS INC shareholders